![]() | ![]() |
Formats:
|
||||||||||
Copyright © 2004, American Society for Microbiology Treponema pallidum Fibronectin-Binding Proteins Department of Medicine, University of Washington, Seattle, Washington *Corresponding author. Mailing address: Box 357185, Department of Medicine, Division of Infectious Diseases, University of Washington, Seattle, WA 98195. Phone: (206) 616-9046. Fax: (206) 685-8681. E-mail: caroc/at/u.washington.edu. Received March 24, 2004; Accepted July 19, 2004. This article has been cited by other articles in PMC.Abstract Putative adhesins were predicted by computer analysis of the Treponema pallidum genome. Two treponemal proteins, Tp0155 and Tp0483, demonstrated specific attachment to fibronectin, blocked bacterial adherence to fibronectin-coated slides, and supported attachment of fibronectin-producing mammalian cells. These results suggest Tp0155 and Tp0483 are fibronectin-binding proteins mediating T. pallidum-host interactions. Syphilis is a chronic infection caused by the spirochete bacterium Treponema pallidum subsp. pallidum. Numerous studies have demonstrated that T. pallidum attaches to host cells (2, 3, 11-14, 16, 21, 37, 45, 48, 50). Experimentally induced infections (7, 36) and in vitro studies (48) have shown that T. pallidum adheres to epithelial surfaces, traverses the tissue barrier, and enters the circulation by invading the tight junctions between endothelial cells. Treponemal invasion results in widespread bacterial dissemination, which sets the stage for establishment of chronic infection. Specific attachment to the extracellular matrix (ECM) component fibronectin has been documented for many pathogenic bacteria, including the related spirochetes Borrelia burgdorferi (19, 35), Leptospira interrogans (26), and Treponema denticola (8-10, 49). Fibronectin is also likely to be involved in T. pallidum cytoadherence. The organism specifically attaches to fibronectin-coated surfaces (21, 34), and fibronectin synthesis by fibroblasts is upregulated in areas of ulceration, including syphilis chancres formed at the primary site of infection. In addition, pretreatment of host cells with antiserum to fibronectin, but not control irrelevant antiserum, inhibits attachment of T. pallidum (21, 34, 45). Finally, three T. pallidum fibronectin-binding proteins, designated P1, P2, and P3, were previously identified by fibronectin affinity chromatography and radioimmunoprecipitation techniques (1, 33, 34, 46). The molecular masses of these proteins were determined to be 89.5, 37, and 32 kDa for P1, P2, and P3, respectively (46); however, their molecular identities remain unknown. T. pallidum fibronectin-binding proteins. To identify T. pallidum fibronectin-binding proteins, 10 potential adhesins were tested for their capacity to mediate attachment of fibronectin. These putative adhesins were identified via bioinformatic analysis of the T. pallidum genome (18) and expressed as recombinant proteins, as described in detail elsewhere (5). Enzyme-linked immunosorbent assay (ELISA) plates (Nalge Nunc International, Rochester, N.Y.) were coated for 16 h at room temperature with 100 μl of the recombinant T. pallidum proteins, a positive control S. aureus fibronectin-binding protein (FnbpA) (41), and a negative control recombinant protein (SA85-1.1) (23), all at a concentration of 5 μg/ml in phosphate-buffered saline (PBS). Wells were subsequently washed three times with PBS. For the adherence assays, 100 μl of either soluble or matrix fibronectin (Sigma, St. Louis, Mo.) was added to the wells at a concentration of 5 μg/ml. To test for the dose-dependent attachment of fibronectin, 100 μl of various matrix or soluble fibronectin concentrations ranging from 0 to 5 μg/ml in PBS was added to the wells. After incubation for 1 h at room temperature, wells were washed six times with PBS with 0.05% Tween-20 (PBST) and bound fibronectin was detected with rabbit anti-human fibronectin (1:500 dilution; Sigma) and goat anti-rabbit immunoglobulin G-horseradish peroxidase conjugate (1:2,000; Sigma) followed by the TMB Microwell peroxidase substrate (Kirkegaard and Perry Laboratories, Gaithersburg, Md.). Optical densities were read at 600 nm with an ELISA plate reader (Bio-Tek Instruments, Winooski, Vt.). Of the panel of expressed T. pallidum recombinant proteins, fibronectin exhibited a significant level of attachment to Tp0155 and Tp0483 (P < 0.05) (Fig. (Fig.1).1
Inhibition experiments. The involvement of Tp0155 and Tp0483 in mediating attachment of T. pallidum to fibronectin was directly assayed via in vitro inhibition experiments. Slides were coated with 4 μg of matrix fibronectin in PBS on Lab-Tek II chamber slides (Nalge Nunc International) by incubation for 16 h at room temperature. After washing with PBS, slides were blocked for 2 h with 3% bovine serum albumin. Inhibition experiments were performed by preincubating fibronectin-coated slides with 200-μg/ml samples of either Tp0155 or Tp0483, both Tp0155 and Tp0483, or the negative control recombinant proteins Tp0751 and Tp0952. After washing with PBS, slides were incubated for 2 h at 34°C with 3 × 107 Percoll-purified T. pallidum (20). After gentle washing with saline (10 times for 5 min each), the attached spirochetes were visualized by dark-field microscopy and quantitative attachment was determined by calculating the number of attached treponemes per field. As shown in Fig. Fig.3,3
Attachment of mammalian cells to Tp0155 and Tp0483. Adhesion assays were performed to investigate the ability of Tp0155 and Tp0483 to mediate attachment of mammalian cells. Cell lines were obtained from the American Type Culture Collection (Manassas, Va.) and included the colon carcinoma cell line SW480, which produces fibronectin, and the pituitary cell line AtT20, which does not synthesize fibronectin or express fibronectin-binding receptors. Assays were performed as previously described (38). Non-tissue culture-treated ELISA plates (Fisher Scientific, Pittsburgh, Pa.) were coated for 24 h at 4°C with 100 μl of either of the recombinant T. pallidum proteins Tp0155 and Tp0483 or the negative control protein bovine serum albumin at a concentration of 20 μg/ml in PBS. Wells coated with Tp0155 and Tp0483 demonstrated a fourfold-higher level of attachment of SW480 than AtT20 cells (data not shown). These results are consistent with the capacity of Tp0155 and Tp0483 to attach to fibronectin. Summary. This study extends previous investigations on the specific interaction of T. pallidum with fibronectin (1, 4, 15, 16, 21, 33, 34, 45-47). Adherence assays identified the T. pallidum open reading frames Tp0155 and Tp0483 as encoding proteins that bind fibronectin. The predicted sizes of Tp0155 (35.8 kDa) and Tp0483 (40 kDa) are similar to the sizes estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis for the previously identified T. pallidum fibronectin-binding proteins P3 (32 kDa) and P2 (37 kDa) (46). The binding of fibronectin to Tp0155 and Tp0483 is characteristic of specific receptor-ligand interactions, in that each molecule bound increasing fibronectin concentrations in a dose-dependent manner. Recombinant Tp0155 and Tp0483 inhibited attachment of T. pallidum to fibronectin, and the two proteins mediated attachment of the fibronectin-producing SW480 cell line. These results identify Tp0155 and Tp0483 as T. pallidum fibronectin-binding proteins. As discussed in this report, Tp0155 preferentially bound the matrix form of fibronectin, whereas Tp0483 bound both the soluble and matrix forms of fibronectin. The two forms of fibronectin exist in different conformational states, with cryptic epitopes becoming exposed during fibronectin matrix assembly (44, 51). Similar differential fibronectin binding abilities have been observed in group B streptococci (43), Streptococcus sanguis (25), Yersinia sp. (40), and human immunodeficiency virus (44), which bind preferentially to the matrix form of fibronectin, and Streptococcus pyogenes (30) and Staphylococcus aureus (24), which bind to both soluble and matrix forms. The differential fibronectin binding capabilities of Tp0155 and Tp0483 would each result in T. pallidum attachment to cells and tissues. Tp0155 could mediate attachment of T. pallidum through direct binding of matrix-associated fibronectin. Further, Tp0483 could mediate both direct binding to cells via matrix-associated fibronectin, as well as indirect binding via soluble fibronectin serving as a bridging molecule between the T. pallidum Tp0483 receptor and cells. Such an attachment mechanism has been observed with other bacterial pathogens, including S. aureus (17, 32, 42), S. pyogenes (6, 29, 31), and Mycobacterium leprae (39). These alternative mechanisms for promoting attachment of T. pallidum to fibronectin may allow the pathogen to colonize different niches in the host. The presence of multiple fibronectin-binding proteins within one organism has been observed for other pathogenic bacteria, including Mycobacterium, Streptococcus, and Staphylococcus spp. (22). We now show that T. pallidum similarly expresses multiple fibronectin-binding adhesins. In addition, T. pallidum also possesses a laminin-binding adhesin (5). The exact contribution of each of these adhesins, as well as other currently unidentified T. pallidum adhesins, to the infection process remains to be determined. However, it is likely that the role in treponemal pathogenesis played by an individual adhesin is particularly suited to the stage of infection and/or tissue niche, with appropriate redundancy existing between these adhesins to ensure successful establishment of infection. Additional characterization of these treponemal fibronectin-binding adhesins, as well as other T. pallidum molecules that interact with host components, will further our understanding of the pathogenesis of T. pallidum. Acknowledgments We are grateful to Lynn Barrett for assistance with recombinant expression, Julie Yabu and Melissa Steadele for their assistance with the cell adhesion assays, and Barbara Molini and Sheila Lukehart for their gift of T. pallidum. This work was supported by Public Health Service grant AI-51334 from the National Institutes of Health, faculty awards from the University of Washington (Royalty Research Fund and STD New Investigator Award, AI-31448), and the Canadian Institutes of Health Research. REFERENCES 1. Alderete, J. F., and J. B. Baseman. 1980. Surface characterization of virulent Treponema pallidum. Infect. Immun. 30:814-823. [PubMed] 2. Baseman, J. B. and J. F. Alderete. 1983. The parasitic strategies of Treponema pallidum, p. 229-239. In R. Schell and D. Musher (ed.), Pathogenesis and immunology of Treponema infections. Marcel Dekker, New York, N.Y. 3. Baseman, J. B., and E. C. Hayes. 1980. Molecular characterization of receptor binding proteins and immunogens of virulent Treponema pallidum. J. Exp. Med. 151:573-586. [PubMed] 4. Baughn, R. E. 1986. Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum. Infect. Immun. 54:456-464. [PubMed] 5. Cameron, C. E. 2003. Identification of a Treponema pallidum laminin-binding protein. Infect. Immun. 71:2525-2533. [PubMed] 6. Cue, D., P. E. Dombek, H. Lam, and P. P. Cleary. 1998. Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect. Immun. 66:4593-4601. [PubMed] 7. Cumberland, M. C., and T. B. Turner. 1949. Rate of multiplication of Treponema pallidum in normal and immune rabbits. Am. J. Syph. 33:201-212. 8. Dawson, J. R., and R. P. Ellen. 1990. Tip-oriented adherence of Treponema denticola to fibronectin. Infect. Immun. 58:3924-3928. [PubMed] 9. Dawson, J. R., and R. P. Ellen. 1994. Clustering of fibronectin adhesins toward Treponema denticola tips upon contact with immobilized fibronectin. Infect. Immun. 62:2214-2221. [PubMed] 10. Fenno, J. C., K.-H. Müller, and B. C. McBride. 1996. Sequence analysis, expression, and binding activity of recombinant major outer sheath protein (Msp) of Treponema denticola. J. Bacteriol. 178:2489-2497. [PubMed] 11. Fitzgerald, T. J., P. Cleveland, R. C. Johnson, J. N. Miller, and J. A. Sykes. 1977. Scanning electron microscopy of Treponema pallidum (Nichols strain) attached to cultured mammalian cells. J. Bacteriol. 130:1333-1344. [PubMed] 12. Fitzgerald, T. J., R. C. Johnson, J. N. Miller, and J. A. Sykes. 1977. Characterization of the attachment of Treponema pallidum (Nichols strain) to cultured mammalian cells and the potential relationship of attachment to pathogenicity. Infect. Immun. 18:467-478. [PubMed] 13. Fitzgerald, T. J., R. C. Johnson, J. A. Sykes, and J. N. Miller. 1977. Interaction of Treponema pallidum (Nichols strain) with cultured mammalian cells: effects of oxygen, reducing agents, serum supplements, and different cell types. Infect. Immun. 15:444-452. [PubMed] 14. Fitzgerald, T. J., J. N. Miller, and J. A. Sykes. 1975. Treponema pallidum (Nichols strain) in tissue cultures: cellular attachment, entry, and survival. Infect. Immun. 11:1133-1140. [PubMed] 15. Fitzgerald, T. J., and L. A. Repesh. 1985. Interactions of fibronectin with Treponema pallidum. Genitourin. Med. 61:147-155. [PubMed] 16. Fitzgerald, T. J., L. A. Repesh, D. R. Blanco, and J. N. Miller. 1984. Attachment of Treponema pallidum to fibronectin, laminin, collagen IV, and collagen I, and blockage of attachment by immune rabbit IgG. Br. J. Vener. Dis. 60:357-363. [PubMed] 17. Fowler, T., E. R. Wann, D. Joh, S. Johansson, T. J. Foster, and M. Höök. 2000. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur. J. Cell Biol. 79:672-679. [PubMed] 18. Fraser, C. M., S. J. Norris, G. M. Weinstock, O. White, G. G. Sutton, R. Dodson, M. Gwinn, E. K. Hickey, R. Clayton, K. A. Ketchum, E. Sodergren, J. M. Hardham, M. P. McLeod, S. Salzberg, J. Peterson, H. Khalak, D. Richardson, J. K. Howell, M. Chidambaram, T. Utterback, L. McDonald, P. Artiach, C. Bowman, M. D. Cotton, C. Fujii, S. Garland, B. Hatch, K. Horst, L. Watthey, J. Weidman, H. O. Smith, and J. C. Venter. 1998. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281:375-388. [PubMed] 19. Grab, D. J., C. Givens, and R. Kennedy. 1998. Fibronectin-binding activity in Borrelia burgdorferi. Biochim. Biophys. Acta 1407:135-145. [PubMed] 20. Hanff, P. A., S. J. Norris, M. A. Lovett, and J. N. Miller. 1984. Purification of Treponema pallidum, Nichols strain, by Percoll density gradient centrifugation. Sex. Transm. Dis. 11:275-286. [PubMed] 21. Hayes, N. S., K. E. Muse, A. M. Collier, and J. B. Baseman. 1977. Parasitism by virulent Treponema pallidum of host cell surfaces. Infect. Immun. 17:174-186. [PubMed] 22. Joh, D., E. R. Wann, B. Kreikemeyer, P. Speziale, and M. Höök. 1999. Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. Matrix Biol. 18:211-223. [PubMed] 23. Kahn, S. J., and M. Wleklinski. 1997. The surface glycoproteins of Trypanosoma cruzi encode a superfamily of variant T cell epitopes. J. Immunol. 159:4444-4451. [PubMed] 24. Kuusela, P., T. Vartio, M. Vuento, and E. B. Myhre. 1985. Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phase. Infect. Immun. 50:77-81. [PubMed] 25. Lowrance, J. H., D. L. Hasty, and W. A. Simpson. 1988. Adherence of Streptococcus sanguis to conformationally specific determinants in fibronectin. Infect. Immun. 56:2279-2285. [PubMed] 26. Merien, F., J. Truccolo, G. Baranton, and P. Perolat. 2000. Identification of a 36-kDa fibronectin-binding protein expressed by a virulent variant of Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol. Lett. 185:17-22. [PubMed] 27. Morla, A., and E. Ruoslahti. 1992. A fibronectin self-assembly site involved in fibronectin matrix assembly: reconstruction in a synthetic peptide. J. Cell Biol. 118:421-429. [PubMed] 28. Morla, A., Z. Zhang, and E. Ruoslahti. 1994. Superfibronectin is a functionally distinct form of fibronectin. Nature 367:193-196. [PubMed] 29. Okada, N., I. Tatsuno, E. Hanski, M. Caparon, and C. Sasakawa. 1998. Streptococcus pyogenes protein F promotes invasion of HeLa cells. Microbiology 144:3079-3086. [PubMed] 30. Okada, N., M. Watarai, V. Ozeri, E. Hanski, M. Caparon, and C. Sasakawa. 1997. A matrix form of fibronectin mediates enhanced binding of Streptococcus pyogenes to host tissue. J. Biol. Chem. 272:26978-26984. [PubMed] 31. Ozeri, V., I. Rosenshine, D. F. Mosher, R. Fassler, and E. Hanski. 1998. Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1. Mol. Microbiol. 30:625-637. [PubMed] 32. Peacock, S. J., T. J. Foster, B. J. Cameron, and A. R. Berendt. 1999. Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells. Microbiology 145:3477-3486. [PubMed] 33. Peterson, K., J. B. Baseman, and J. F. Alderete. 1987. Molecular cloning of Treponema pallidum outer envelope fibronectin binding proteins, P1 and P2. Genitourin. Med. 63:355-360. [PubMed] 34. Peterson, K. M., J. B. Baseman, and J. F. Alderete. 1983. Treponema pallidum receptor binding proteins interact with fibronectin. J. Exp. Med. 157:1958-1970. [PubMed] 35. Probert, W. S., and B. J. Johnson. 1998. Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol. Microbiol. 30:1003-1015. [PubMed] 36. Raiziss, G. W., and M. Severac. 1937. Rapidity with which Spirochaeta pallida invades the bloodstream. Arch. Dermatol. Syphilol. 35:1101-1109. 37. Rice, M., and T. J. Fitzgerald. 1985. Detection and functional characterization of early appearing antibodies in rabbits with experimental syphilis. Can. J. Microbiol. 31:62-67. [PubMed] 38. Schnapp, L. M., N. Hatch, D. M. Ramos, I. V. Klimanskaya, D. Sheppard, and R. Pytela. 1995. The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin. J. Biol. Chem. 270:23196-23202. [PubMed] 39. Schorey, J. S., Q. Li, D. W. McCourt, M. Bong-Mastek, J. E. Clark-Curtiss, T. L. Ratliff, and E. J. Brown. 1995. A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells. Infect. Immun. 63:2652-2657. [PubMed] 40. Schulze-Koops, H., H. Burkhardt, J. Heesemann, T. Kirsch, B. Swoboda, C. Bull, S. Goodman, and F. Emmrich. 1993. Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect. Immun. 61:2513-2519. [PubMed] 41. Signäs, C., G. Raucci, K. Jonsson, P. E. Lindgren, G. M. Anantharamaiah, M. Höök, and M. Lindberg. 1989. Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc. Natl. Acad. Sci. USA 86:699-703. [PubMed] 42. Sinha, B., P. P. Francois, O. Nusse, M. Foti, O. M. Hartford, P. Vaudaux, T. J. Foster, D. P. Lew, M. Herrmann, and K. H. Krause. 1999. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell. Microbiol. 1:101-117. [PubMed] 43. Tamura, G. S., and C. E. Rubens. 1995. Group B streptococci adhere to a variant of fibronectin attached to a solid phase. Mol. Microbiol. 15:581-589. [PubMed] 44. Tellier, M. C., G. Greco, M. Klotman, A. Mosoian, A. Cara, W. Arap, E. Ruoslahti, R. Pasqualini, and L. M. Schnapp. 2000. Superfibronectin, a multimeric form of fibronectin, increases HIV infection of primary CD4+ T lymphocytes. J. Immunol. 164:3236-3245. [PubMed] 45. Thomas, D. D., J. B. Baseman, and J. F. Alderete. 1985. Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domain. J. Exp. Med. 161:514-525. [PubMed] 46. Thomas, D. D., J. B. Baseman, and J. F. Alderete. 1985. Putative Treponema pallidum cytadhesins share a common functional domain. Infect. Immun. 49:833-835. [PubMed] 47. Thomas, D. D., J. B. Baseman, and J. F. Alderete. 1986. Enhanced levels of attachment of fibronectin-primed Treponema pallidum to extracellular matrix. Infect. Immun. 52:736-741. [PubMed] 48. Thomas, D. D., M. Navab, D. A. Haake, A. M. Fogelman, J. N. Miller, and M. A. Lovett. 1988. Treponema pallidum invades intercellular junctions of endothelial cell monolayers. Proc. Natl. Acad. Sci. USA. 85:3608-3612. [PubMed] 49. Umemoto, T., Y. Nakatani, Y. Nakamura, and I. Namikawa. 1993. Fibronectin-binding proteins of a human oral spirochete Treponema denticola. Microbiol. Immunol. 37:75-78. [PubMed] 50. Wong, G. H. W., B. Steiner, and S. Graves. 1983. Effect of syphilitic rabbit sera taken at different periods after infection on treponemal motility, treponemal attachment to mammalian cells in vitro, and treponemal infection in rabbits. Br. J. Vener. Dis. 59:220-224. [PubMed] 51. Zhong, C., M. Chrzanowska-Wodnicka, J. Brown, A. Shaub, A. M. Belkin, and K. Burridge. 1998. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 141:539-551. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||
J Exp Med. 1980 Mar 1; 151(3):573-86.
[J Exp Med. 1980]J Bacteriol. 1977 Jun; 130(3):1333-44.
[J Bacteriol. 1977]Infect Immun. 1975 May; 11(5):1133-40.
[Infect Immun. 1975]Br J Vener Dis. 1984 Dec; 60(6):357-63.
[Br J Vener Dis. 1984]Infect Immun. 1977 Jul; 17(1):174-86.
[Infect Immun. 1977]Biochim Biophys Acta. 1998 Aug 14; 1407(2):135-45.
[Biochim Biophys Acta. 1998]Mol Microbiol. 1998 Dec; 30(5):1003-15.
[Mol Microbiol. 1998]FEMS Microbiol Lett. 2000 Apr 1; 185(1):17-22.
[FEMS Microbiol Lett. 2000]Infect Immun. 1990 Dec; 58(12):3924-8.
[Infect Immun. 1990]J Bacteriol. 1996 May; 178(9):2489-97.
[J Bacteriol. 1996]Science. 1998 Jul 17; 281(5375):375-88.
[Science. 1998]Infect Immun. 2003 May; 71(5):2525-33.
[Infect Immun. 2003]Proc Natl Acad Sci U S A. 1989 Jan; 86(2):699-703.
[Proc Natl Acad Sci U S A. 1989]J Immunol. 1997 Nov 1; 159(9):4444-51.
[J Immunol. 1997]J Cell Biol. 1992 Jul; 118(2):421-9.
[J Cell Biol. 1992]Nature. 1994 Jan 13; 367(6459):193-6.
[Nature. 1994]Sex Transm Dis. 1984 Oct-Dec; 11(4):275-86.
[Sex Transm Dis. 1984]J Biol Chem. 1995 Sep 29; 270(39):23196-202.
[J Biol Chem. 1995]Infect Immun. 1980 Dec; 30(3):814-23.
[Infect Immun. 1980]Infect Immun. 1986 Nov; 54(2):456-64.
[Infect Immun. 1986]Genitourin Med. 1985 Jun; 61(3):147-55.
[Genitourin Med. 1985]Br J Vener Dis. 1984 Dec; 60(6):357-63.
[Br J Vener Dis. 1984]Infect Immun. 1977 Jul; 17(1):174-86.
[Infect Immun. 1977]J Immunol. 2000 Mar 15; 164(6):3236-45.
[J Immunol. 2000]J Cell Biol. 1998 Apr 20; 141(2):539-51.
[J Cell Biol. 1998]Mol Microbiol. 1995 Feb; 15(3):581-9.
[Mol Microbiol. 1995]Infect Immun. 1988 Sep; 56(9):2279-85.
[Infect Immun. 1988]Infect Immun. 1993 Jun; 61(6):2513-9.
[Infect Immun. 1993]Matrix Biol. 1999 Jun; 18(3):211-23.
[Matrix Biol. 1999]Infect Immun. 2003 May; 71(5):2525-33.
[Infect Immun. 2003]